Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.

[This corrects the article DOI: 10.1371/journal.pone.0158888.].

Bibliographic Details
Main Authors: Satoshi Kawano, Alexandra R Grassian, Masumi Tsuda, Sarah K Knutson, Natalie M Warholic, Galina Kuznetsov, Shanqin Xu, Yonghong Xiao, Roy M Pollock, Jesse J Smith, Kevin W Kuntz, Scott Ribich, Yukinori Minoshima, Junji Matsui, Robert A Copeland, Shinya Tanaka, Heike Keilhack
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5234811?pdf=render
_version_ 1828865422877786112
author Satoshi Kawano
Alexandra R Grassian
Masumi Tsuda
Sarah K Knutson
Natalie M Warholic
Galina Kuznetsov
Shanqin Xu
Yonghong Xiao
Roy M Pollock
Jesse J Smith
Kevin W Kuntz
Scott Ribich
Yukinori Minoshima
Junji Matsui
Robert A Copeland
Shinya Tanaka
Heike Keilhack
author_facet Satoshi Kawano
Alexandra R Grassian
Masumi Tsuda
Sarah K Knutson
Natalie M Warholic
Galina Kuznetsov
Shanqin Xu
Yonghong Xiao
Roy M Pollock
Jesse J Smith
Kevin W Kuntz
Scott Ribich
Yukinori Minoshima
Junji Matsui
Robert A Copeland
Shinya Tanaka
Heike Keilhack
author_sort Satoshi Kawano
collection DOAJ
description [This corrects the article DOI: 10.1371/journal.pone.0158888.].
first_indexed 2024-12-13T04:28:53Z
format Article
id doaj.art-794b53db2605483789c901bbe947d23f
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T04:28:53Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-794b53db2605483789c901bbe947d23f2022-12-21T23:59:38ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01121e017053910.1371/journal.pone.0170539Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.Satoshi KawanoAlexandra R GrassianMasumi TsudaSarah K KnutsonNatalie M WarholicGalina KuznetsovShanqin XuYonghong XiaoRoy M PollockJesse J SmithKevin W KuntzScott RibichYukinori MinoshimaJunji MatsuiRobert A CopelandShinya TanakaHeike Keilhack[This corrects the article DOI: 10.1371/journal.pone.0158888.].http://europepmc.org/articles/PMC5234811?pdf=render
spellingShingle Satoshi Kawano
Alexandra R Grassian
Masumi Tsuda
Sarah K Knutson
Natalie M Warholic
Galina Kuznetsov
Shanqin Xu
Yonghong Xiao
Roy M Pollock
Jesse J Smith
Kevin W Kuntz
Scott Ribich
Yukinori Minoshima
Junji Matsui
Robert A Copeland
Shinya Tanaka
Heike Keilhack
Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.
PLoS ONE
title Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.
title_full Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.
title_fullStr Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.
title_full_unstemmed Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.
title_short Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.
title_sort correction preclinical evidence of anti tumor activity induced by ezh2 inhibition in human models of synovial sarcoma
url http://europepmc.org/articles/PMC5234811?pdf=render
work_keys_str_mv AT satoshikawano correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma
AT alexandrargrassian correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma
AT masumitsuda correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma
AT sarahkknutson correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma
AT nataliemwarholic correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma
AT galinakuznetsov correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma
AT shanqinxu correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma
AT yonghongxiao correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma
AT roympollock correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma
AT jessejsmith correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma
AT kevinwkuntz correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma
AT scottribich correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma
AT yukinoriminoshima correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma
AT junjimatsui correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma
AT robertacopeland correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma
AT shinyatanaka correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma
AT heikekeilhack correctionpreclinicalevidenceofantitumoractivityinducedbyezh2inhibitioninhumanmodelsofsynovialsarcoma